TIAA CREF INVESTMENT MANAGEMENT LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$10,657,000
+55.8%
158,029
+6.5%
0.01%
+60.0%
Q4 2018$6,842,000
-70.2%
148,394
-50.2%
0.01%
-37.5%
Q3 2018$22,982,000
+85.9%
298,000
+103.0%
0.01%0.0%
Q2 2018$12,365,000
+23.9%
146,798
+20.3%
0.01%
+14.3%
Q1 2018$9,978,000
+61.1%
122,013
+12.6%
0.01%
+75.0%
Q4 2017$6,195,000
-17.7%
108,369
-3.9%
0.00%
-20.0%
Q3 2017$7,530,000
+24.8%
112,813
-3.8%
0.01%
+25.0%
Q2 2017$6,033,000
+15.8%
117,265
+31.4%
0.00%0.0%
Q1 2017$5,211,000
+33.3%
89,235
-4.8%
0.00%
+33.3%
Q4 2016$3,910,000
-12.3%
93,697
+11.0%
0.00%0.0%
Q3 2016$4,459,000
+31.8%
84,412
+4.5%
0.00%0.0%
Q2 2016$3,384,000
+11.2%
80,776
+7.8%
0.00%
+50.0%
Q1 2016$3,042,000
-39.0%
74,924
-2.4%
0.00%
-50.0%
Q4 2015$4,985,000
-8.1%
76,780
-0.1%
0.00%0.0%
Q3 2015$5,427,000
-54.5%
76,880
-28.4%
0.00%
-50.0%
Q2 2015$11,926,000
+158.1%
107,306
+119.0%
0.01%
+166.7%
Q1 2015$4,621,000
-14.3%
49,001
+1.8%
0.00%
-25.0%
Q4 2014$5,395,000
+76.8%
48,151
-3.2%
0.00%
+100.0%
Q3 2014$3,051,000
+31.1%
49,735
-2.1%
0.00%0.0%
Q2 2014$2,328,000
+112.2%
50,807
+81.2%
0.00%
+100.0%
Q1 2014$1,097,000
+63.5%
28,0320.0%0.00%
Q4 2013$671,000
+41.9%
28,032
+65.6%
0.00%
Q3 2013$473,00016,9320.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders